Fructose, weight gain, and the insulin resistance syndrome

American Journal of Clinical Nutrition

Volumn 76, Issue 5, 2002, Pages 911-922

  Elliott, Sharon S ^a   Keim, Nancy L ^b   Stern, Judith S ^a   Teff, Karen ^c   Havel, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fructose; Hypertension; Insulin resistance; Leptin; Obesity; Review; Triacylglycerol; Weight gain

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; ALDEHYDE; ASPARTAME; CARBOHYDRATE; CARRIER PROTEIN; CATECHOLAMINE; CHOLESTEROL; CITRIC ACID; DIHYDROXYACETONE PHOSPHATE; FRUCTOKINASE; FRUCTOSE; FRUCTOSE 1 PHOSPHATE; FRUCTOSE BISPHOSPHATE ALDOLASE; GHRELIN; GLUCOSE; GLYCERALDEHYDE; GLYCERALDEHYDE 3 PHOSPHATE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; STARCH; STEROID; SUCROSE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ARTICLE; BODY MASS; CALORIC INTAKE; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; FOOD INTAKE; FRUCTOSE METABOLISM; GENE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIVER METABOLISM; NONHUMAN; OBESITY; PREVALENCE; WEIGHT GAIN;

ANIMALIA; ZEA MAYS;

EID: 0036828347     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/76.5.911     Document Type: Article

References (134)

1. Grundy SM. Multifactorial causation of obesity: Implications for prevention. Am J Clin Nutr 1998;67(suppl):563S-72S.
2. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-11.
3. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science 1998;280:1371-4.
4. Wickelgren I. Obesity: How big a problem? Science 1998;280:1364-7.
5. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-60.
6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
7. Purnell JQ, Brunzell JD. The central role of dietary fat, not carbohydrate, in the insulin resistance syndrome. Curr Opin Lipidol 1997;8:17-22.
8. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993;92:141-6.
9. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-86.
10. Reaven GM. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 1997;8:23-7.
11. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 2002;13:51-9.
12. Rask E, Olsson T, Soderberg S, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86:1418-21.
13. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-70.
14. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997;46:1594-600.
15. Hill JO, Lin D, Yakubu F, Peters JC. Development of dietary obesity in rats: Influence of amount and composition of dietary fat. Int J Obes Relat Metab Disord 1992;16:321-33.
16. Romieu I, Willett WC, Stampfer MJ, et al. Energy intake and other determinants of relative weight. Am J Clin Nutr 1988;47:406-12.
17. Feskens EJ, Virtanen SM, Rasanen L, et al. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 1995;18:1104-12.
18. Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: The Seven Countries Study. Prev Med 1995;24:308-15.
19. Putnam JJ, Allshouse JE. Food Consumption, Prices, and Expenditures, 1970-97. Washington, DC: Economic Research Service, US Department of Agriculture, 1999.
20. Bhosale SH, Rao MB, Deshpande VV. Molecular and industrial aspects of glucose isomerase. Microbiol Rev 1996;60:280-300.
21. Park YK, Yetley EA. Intakes and food sources of fructose in the United States. Am J Clin Nutr 1993;58(suppl):737S-47S.
22. Guzman-Maldonado H, Paredes-Lopez O. Amylolytic enzymes and products derived from starch: A review. Crit Rev Food Sci Nutr 1995;35:373-403.
23. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr 1993;58(suppl):754S-65S.
24. Shiota M, Galassetti P, Monohan M, Neal DW, Cherrington AD. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes 1998;47:867-73.
25. Petersen KF, Laurent D, Yu C, Cline GW, Shulman GI. Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Diabetes 2001;50:1263-8.
26. Hawkins MA, Wozniak R, Gabriely I, Mevorach M, Shamoon H, Rossetti L. Fructose restores the ability of hyperglycemia per se to regulate hepatic glucose production (GP) in type 2 diabetes mellitus (DM2). Diabetes 1999;48:A292 (abstr).
27. Moore MC, Mann SL, Converse M, Penaloza A. Fructose decreases the glucose and insulin responses to an oral glucose tolerance test (OGTT) in individuals with type 2 diabetes (DM2). Diabetes 2000;49:A84 (abstr).
28. Glinsmann WH, Bowman BA. The public health significance of dietary fructose. Am J Clin Nutr 1993;58(suppl):820S-3S.
29. Schwarz JM, Neese RA, Schakleton C, Hellerstein MK. De novo lipogenesis during fasting and oral fructose ingestion in lean and obese hyperinsulinemic subjects. Diabetes 1993;42(suppl):A39 (abstr).
30. Schwarz J-M, Neese RA, Turner SM, Nguyen C, Hellerstein MK. Effect of fructose ingestion on glucose production (GP) and de novo lipogenesis (DNL) in normal and hyperinsulinemic obese humans. Diabetes 1994;43(suppl):52A (abstr).
31. Hellerstein MK, Schwarz JM, Neese RA. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 1996;16:523-57.
32. Jeppesen J, Chen YI, Zhou MY, Schaaf P, Coulston A, Reaven GM. Postprandial triglyceride and retinyl ester responses to oral fat: Effects of fructose. Am J Clin Nutr 1995;61:787-91.
33. Abraha A, Humphreys SM, Clark ML, Matthews DR, Frayn KN. Acute effect of fructose on postprandial lipaemia in diabetic and non-diabetic subjects. Br J Nutr 1998;80:169-75.
34. Kanarek RB, Orthen-Gambill N. Differential effects of sucrose, fructose and glucose on carbohydrate-induced obesity in rats. J Nutr 1982;112:1546-54.
35. Rizkalla SW, Boillot J, Tricottet V, et al. Effects of chronic dietary fructose with and without copper supplementation on glycaemic control, adiposity, insulin binding to adipocytes and glomerular basement membrane thickness in normal rats. Br J Nutr 1993;70:199-209.
36. Kasim-Karakas SE, Vriend H, Almario R, Chow LC, Goodman MN. Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. J Lab Clin Med 1996;128:208-13.
37. Tordoff MG, Alleva AM. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight. Am J Clin Nutr 1990;51:963-9.
38. Anderson JW, Story LJ, Zettwoch NC, Gustafson NJ, Jefferson BS. Metabolic effects of fructose supplementation in diabetic individuals. Diabetes Care 1989;12:337-44.
39. Astrup A, Raben A, Vasilaras TH, Moller AC. Sucrose in soft drinks is fattening: A randomized 10 week study in overweight subjects. Am J Clin Nutr 2002;75(suppl):405S (abstr).
40. Grant AM, Christie MR, Ashcroft SJ. Insulin release from human pancreatic islets in vitro. Diabetologia 1980;19:114-7.
41. Curry DL. Effects of mannose and fructose on the synthesis and secretion of insulin. Pancreas 1989;4:2-9.
42. Sato Y, Ito T, Udaka N, et al. Immunohistochemical localization of facilitated-diffusion glucose transporters in rat pancreatic islets. Tissue Cell 1996;28:637-43.
43. Woods SC, Chavez M, Park CR, et al. The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev 1996;20:139-44.
44. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-71.
45. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 2000;49:1525-33.
46. Brüning JC, Gautam D, Burks DJ, et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000;289:2122-5.
47. Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C. Reduced insulin secretion: An independent predictor of body weight gain. J Clin Endocrinol Metab 1995;80:1571-6.
48. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32. (Published erratum appears in Nature 1995;374:479.)
49. Masuzaki H, Ogawa Y, Isse N, et al. Human obese gene expression. Adipocyte-specific expression and regional differences in adipose tissue. Diabetes 1995;44:855-8.
50. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: The tale of an obesity gene. Diabetes 1996;45:1455-62.
51. Rohner-Jeanrenaud F, Jeanrenaud B. Obesity, leptin, and the brain. N Engl J Med 1996;334:324-5 (editorial).
52. Niswender KD, Morton GJ, Steams WH, Rhodes CJ, Myers MG Jr, Schwartz MW. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 2001;413:794-5.
53. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997;100:270-8.
54. Havel PJ, Pelleymounter M. Acute adrenergically-mediated increases of circulating glucose and lactate after leptin administration in rhesus monkeys. Obes Res 1997;5:17S (abstr).
55. Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab 1999;84:711-7.
56. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8.
57. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
58. Farooqi S, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879-84.
59. Farooqi IS, Keogh JM, Kamath S, et al. Partial leptin deficiency and human adiposity. Nature 2001;414:34-5.
60. Keim NL, Stern JS, Havel PJ. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr 1998;68:794-801.
61. Westerterp-Plantenga MS, Saris WH, Hukshorn CJ, Campfield LA. Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am J Clin Nutr 2001;74:426-34.
62. Havel PJ. Leptin production and action: Relevance to energy balance in humans. Am J Clin Nutr 1998;67:355-6 (editorial).
63. Ahren B, Mansson S, Gingerich RL, Havel PJ. Regulation of plasma leptin in mice: Influence of age, high-fat diet, and fasting. Am J Physiol 1997;273:R113-20.
64. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nat Med 1995;1:1155-61.
65. Havel PJ. Glucose but not fructose infusion increases circulating leptin in proportion to adipose stores in rhesus monkeys. Exp Clin Endocrinol Diabetes 1997;105:37-8.
66. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: Effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 1996;81:4406-13.
67. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 1997;82:561-5.
68. Dubuc GR, Phinney SD, Stern JS, Havel PJ. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 1998;47:429-34.
69. Havel PJ. Peripheral signals conveying metabolic information to the brain: Short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med 2001;226:963-77.
70. Sinha MK, Ohannesian JP, Heiman ML, et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996;97:1344-7.
71. Schoeller DA, Cella LK, Sinha MK, Caro JF. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 1997;100:1882-7.
72. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996;81:3419-23.
73. Saad MF, Khan A, Sharma A, et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes 1998;47:544-9.
74. Mueller WM, Gregoire FM, Stanhope KL, et al. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 1998;139:551-8.
75. Moreno-Aliaga MJ, Stanhope KL, Havel PJ. Transcriptional regulation of the leptin promoter by insulin-stimulated glucose metabolism in 3t3-11 adipocytes. Biochem Biophys Res Comm 2001;283:544-8.
76. Mueller WM, Stanhope KL, Gregoire F, Evans JL, Havel PJ. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obes Res 2000;8:530-9.
77. Wellhoener P, Fruehwald-Schultes B, Kern W, et al. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab 2000;85:1267-71.
78. Laughlin GA, Yen SS. Hypoleptinemia in women athletes: Absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997;82:318-21.
79. Saad MF, Riad-Gabriel MG, Khan A, et al. Diurnal and ultradian rhythmicity of plasma leptin: Effects of gender and adiposity. J Clin Endocrinol Metab 1998;83:453-9.
80. Havel PJ, Townsend R, Chaump L, Teff K. High fat meals reduce 24-hour circulating leptin concentrations in women. Diabetes 1999;48:334-41.
81. Poppitt SD, Keogh GF, Prentice AM, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr 2002;75:11-20.
82. Horton TJ, Drougas H, Brachey A, Reed GW, Peters JC, Hill JO. Fat and carbohydrate overfeeding in humans: Different effects on energy storage. Am J Clin Nutr 1995;62:19-29.
83. Tataranni PA, Ravussin E. Effect of fat intake on energy balance. Ann NY Acad Sci 1997;819:37-43.
84. Tremblay A, Plourde G, Despres JP, Bouchard C. Impact of dietary fat content and fat oxidation on energy intake in humans. Am J Clin Nutr 1989;49:799-805.
85. Havel PJ, Elliott SS, Tschoep M, et al. Consuming high fructose meals reduces 24 hour circulating insulin and leptin concentrations and does not suppress circulating ghrelin in women. J Invest Med 2002;50:26A (abstr).
86. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-9.
87. Hallfrisch J, Lazar F, Jorgensen C, Reiser S. Insulin and glucose responses in rats fed sucrose or starch. Am J Clin Nutr 1979;32:787-93.
88. Reiser S, Hallfrisch J. Insulin sensitivity and adipose tissue weight of rats fed starch or sucrose diets ad libitum or in meals. J Nutr 1977;107:147-55.
89. Zavaroni I, Sander S, Scott S, Reaven GM. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 1980;29:970-3.
90. Martinez FJ, Rizza RA, Romero JC. High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension 1994;23:456-63.
91. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 1989;49:1155-63.
92. Fields M, Lewis CG, Lure MD. Responses of insulin to oral glucose and fructose loads in marginally copper-deficient rats fed starch or fructose. Nutrition 1996;12:524-8.
93. Blakely SR, Hallfrisch J, Reiser S, Prather ES. Long-term effects of moderate fructose feeding on glucose tolerance parameters in rats. J Nutr 1981;111:307-14.
94. Beck-Nielsen H, Pedersen O, Lindskov HO. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr 1980;33:273-8.
95. Hallfrisch J, Ellwood KC, Michaelis OE, Reiser S, O'Dorisio TM, Prather ES. Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J Nutr 1983;113:1819-26.
96. McGarry JD. Disordered metabolism in diabetes: Have we underemphasized the fat component? J Cell Biochem 1994;55(suppl):29-38.
97. Jéquier E, Tappy L. Regulation of body weight in humans, Physiol Rev 1999;79:451-80.
98. Virkamäki A, Korsheninnikova E, Seppälä-Lindroos A, et al. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 2001;50:2337-43.
99. Rebrin K, Steil GM, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995;44:1038-45.
100. Steil GM, Rebrin K, Mittelman SD, Bergman RN. Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes 1998;47:714-20.
101. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000;11:351-6.
102. Arner P. Free fatty acids - Do they play a central role in type 2 diabetes? Diabetes Obes Metab 2001;3(suppl):S11-9.
103. Bieger WP, Michel G, Barwich D, Biehl K, Wirth A. Diminished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia. Metabolism 1984;33:982-7.
104. Storlien LH, Oakes ND, Pan DA, Kusunoki M, Jenkins AB. Syndromes of insulin resistance in the rat. Inducement by diet and amelioration with benfluorex. Diabetes 1993;42:457-62.
105. Jeng CY, Sheu WH, Fuh MM, Shieh SM, Chen YD, Reaven GM. Gemfibrozil treatment of endogenous hypertriglyceridemia: Effect on insulin-mediated glucose disposal and plasma insulin concentrations. J Clin Endocrinol Metab 1996;81:2550-3.
106. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
107. Herman RH, Zakim D, Stifel FB. Effect of diet on lipid metabolism in experimental animals and man. Fed Proc 1970;29:1302-7.
108. Inoue I, Takahashi K, Katayama S, et al. Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats. Metabolism 1995;44:1626-30.
109. Okazaki M, Zhang H, Yoshida Y, Ichino K, Nakayama S, Oguchi K. Correlation between plasma fibrinogen and serum lipids in rats with hyperlipidemia induced by cholesterol free-high fructose or high cholesterol diet. J Nutr Sci Vitaminol (Tokyo) 1994;40:479-89.
110. Fields M, Lewis CG. Dietary fructose but not starch is responsible for hyperlipidemia associated with copper deficiency in rats: Effect of high-fat diet. J Am Coll Nutr 1999;18:83-7.
111. Hellerstein MK. Synthesis of fat in response to alterations in diet: Insights from new stable isotope methodologies. Lipids 1996;31(suppl):S117-25.
112. Schwarz JM, Neese RA, Basinger A, Hellerstein MK. Effect of oral fructose on lipolysis, fat oxidation, fractional and absolute de novo lipogenesis (DNL) using mass isotopomer distribution analysis (MIDA). FASEB J 1993;7:A867 (abstr).
113. Reiser S. Effects of dietary sugars in metabolic risk factors associated with heart disease. Nutr Health 1985;3:203-16.
114. Hallfrisch J, Reiser S, Prather ES. Blood lipid distribution of hyperinsulinemic men consuming three levels of fructose. Am J Clin Nutr 1983;37:740-8.
115. Reiser S, Powell AS, Scholfield DJ, Panda P, Fields M, Canary JJ. Day-long glucose, insulin, and fructose responses of hyperinsulinemic and nonhyperinsulinemic men adapted to diets containing either fructose or high-amylose cornstarch. Am J Clin Nutr 1989;50:1008-14.
116. Huttunen JK, Makinen KK, Scheinin A. Turku sugar studies XI. Effects of sucrose, fructose and xylitol diets on glucose, lipid and urate metabolism. Acta Odontol Scand 1976;34:345-51.
117. Hollenbeck CB. Dietary fructose effects on lipoprotein metabolism and risk for coronary artery disease. Am J Clin Nutr 1993;58:800S-809S.
118. Bantle JP, Raatz SK, Thomas W, Georgopoulos A. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr 2000;72:1128-34.
119. Teff K, Elliott S, Tschoep M, et al. Consuming high fructose meals reduces 24 hour plasma insulin and leptin concentrations, does not suppress circulating ghrelin, and increases postprandial and fasting triglycerides in women. Diabetes 2002;1(suppl):abstract 1672.
120. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: Historical perspective and review of biological mechanisms. Am J Clin Nutr 2000;71:412-33.
121. Taghibiglou C, Carpentier A, Van Iderstine SC, et al. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 2000;275:8416-25.
122. Farris RP. Nicklas TA, Myers L, Berenson GS. Nutrient intake and food group consumption of 10-year-olds by sugar intake level: the Bogalusa Heart Study. J Am Coll Nutr 1998;17:579-85.
123. Dwyer JT, Evans M, Stone EJ, et al. Adolescents' eating patterns influence their nutrient intakes. J Am Diet Assoc 2001;101:798-802.
124. Cavadini C, Siega-Riz AM, Popkin BM. US adolescent food intake trends from 1965 to 1996. Arch Dis Child 2000;83:18-24.
125. Dai S, McNeill JH. Fructose-induced hypertension in rats is concentration- and duration-dependent. J Pharmacol Toxicol Methods 1995;33:101-7.
126. Erlich Y, Rosenthal T. Effect of angiotensin-converting enzyme inhibitors on fructose induced hypertension and hyperinsulinaemia in rats. Clin Exp Pharmacol Physiol 1995;22(suppl): S347-9.
127. Suzuki M, Nomura C, Odaka H, Ikeda H. Effect of an insulin sensitizer, pioglitazone, on hypertension in fructose-drinking rats. Jpn J Pharmacol 1997;74:297-302.
128. Verma S, Bhanot S, McNeill JH. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. J Pharmacol Exp Ther 1994;271:1334-7.
129. Daly ME, Vale C, Walker M, Alberti KG, Mathers JC. Dietary carbohydrates and insulin sensitivity: A review of the evidence and clinical implications. Am J Clin Nutr 1997;66:1072-85.
130. Vasdev S, Ford CA, Longerich L, Gadag V, Wadhawan S. Role of aldehydes in fructose induced hypertension. Mol Cell Biochem 1998;181:1-9.
131. Verma S, Bhanot S, McNeill JH. Decreased vascular reactivity in metformin-treated fructose-hypertensive rats. Metabolism 1996;45:1053-5.
132. Takagawa Y, Berger ME, Hori MT, Tuck ML, Golub MS. Long-term fructose feeding impairs vascular relaxation in rat mesenteric arteries. Am J Hypertens 2001;14:811-7.
133. Giacchetti G, Sechi LA, Griffin CA, Don BR, Mantero F, Schambelan M. The tissue renin-angiotensin system in rats with fructose-induced hypertension: Overexpression of type 1 angiotensin II receptor in adipose tissue. J Hypertens 2000;18:695-702.
134. Coulston AM, Johnson RK. Sugar and sugars: Myths and realities. J Am Diet Assoc 2002;102:351-3.